Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Diamyd Medical AB Changes Name to Mertiva AB, Distributes Shares in Subsidiary to Shareholders and Appoints Hakan Blomdahl as Chairman


Monday, 22 Apr 2013 10:15am EDT 

Diamyd Medical AB announced that it has decided to change its name to Mertiva AB. Its subsidiary Diamyd Therapeutics AB is to take over the name Diamyd Medical AB. The shares of Diamyd Therapeutics AB (future Diamyd Medical AB) are to be distributed to shareholders. Three A shares in the Company give right to one A share in the subsidiary, and three B shares in the Company give right to one B share in the subsidiary. the record date for the right to distribution is April 25, 2013. In addition, Hakan Blomdahl was elected as the new Chairman of the Company's Board of Directors.